AR6P4_HUMAN - dbPTM
AR6P4_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID AR6P4_HUMAN
UniProt AC Q66PJ3
Protein Name ADP-ribosylation factor-like protein 6-interacting protein 4
Gene Name ARL6IP4
Organism Homo sapiens (Human).
Sequence Length 421
Subcellular Localization Nucleus, nucleolus . Nucleus speckle .
Protein Description Involved in modulating alternative pre-mRNA splicing with either 5' distal site activation or preferential use of 3' proximal site. In case of infection by Herpes simplex virus (HSVI), may act as a splicing inhibitor of HSVI pre-mRNA..
Protein Sequence MPRCTYQLEQNPGFLPDGPGVHARAHCQDLSGPYGHEFATSESLGGRVGKTRAPQSGARSRMERAGPAGEEGGAREGRLLPRAPGAWVLRACAERAALEVGAASADTGVRGCGARGPAPLLASAGGGRARDGTWGVRTKGSGAALPSRPASRAAPRPEASSPPLPLEKARGGLSGPQGGRARGAMAHVGSRKRSRSRSRSRGRGSEKRKKKSRKDTSRNCSASTSQGRKASTAPGAEASPSPCITERSKQKARRRTRSSSSSSSSSSSSSSSSSSSSSSSSSDGRKKRGKYKDKRRKKKKKRKKLKKKGKEKAEAQQVEALPGPSLDQWHRSAGEEEDGPVLTDEQKSRIQAMKPMTKEEWDARQSIIRKVVDPETGRTRLIKGDGEVLEEIVTKERHREINKQATRGDCLAFQMRAGLLP
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
37 (in isoform 7)Phosphorylation-5.5229978859
39 (in isoform 7)Phosphorylation-7.0429978859
40 (in isoform 7)Phosphorylation-13.1729978859
41 (in isoform 7)Phosphorylation-11.9229978859
44 (in isoform 7)Phosphorylation-17.4123927012
46 (in isoform 7)Phosphorylation-36.9725849741
50 (in isoform 7)Phosphorylation-16.2929978859
104PhosphorylationALEVGAASADTGVRG
HHHHCCCCCCCCCCC
44.2228258704
107PhosphorylationVGAASADTGVRGCGA
HCCCCCCCCCCCCCC
51.5828258704
117UbiquitinationRGCGARGPAPLLASA
CCCCCCCCCCCEEEC
30.5929967540
129PhosphorylationASAGGGRARDGTWGV
EECCCCCCCCCCCCC
33.2732142685
137PhosphorylationRDGTWGVRTKGSGAA
CCCCCCCEECCCCCC
35.5432142685
141PhosphorylationWGVRTKGSGAALPSR
CCCEECCCCCCCCCC
39.2822468782
147PhosphorylationGSGAALPSRPASRAA
CCCCCCCCCCCCCCC
52.5622468782
151PhosphorylationALPSRPASRAAPRPE
CCCCCCCCCCCCCCC
54.1422468782
152UbiquitinationLPSRPASRAAPRPEA
CCCCCCCCCCCCCCC
50.1532015554
159UbiquitinationRAAPRPEASSPPLPL
CCCCCCCCCCCCCCH
3.32-
160PhosphorylationAAPRPEASSPPLPLE
CCCCCCCCCCCCCHH
28.8923403867
161PhosphorylationAPRPEASSPPLPLEK
CCCCCCCCCCCCHHH
21.0123403867
163UbiquitinationRPEASSPPLPLEKAR
CCCCCCCCCCHHHHC
25.45-
163UbiquitinationRPEASSPPLPLEKAR
CCCCCCCCCCHHHHC
25.4529967540
170MethylationPLPLEKARGGLSGPQ
CCCHHHHCCCCCCCC
28.30-
173UbiquitinationLEKARGGLSGPQGGR
HHHHCCCCCCCCCCC
42.4929967540
174PhosphorylationEKARGGLSGPQGGRA
HHHCCCCCCCCCCCH
33.32-
175UbiquitinationKARGGLSGPQGGRAR
HHCCCCCCCCCCCHH
14.23-
175UbiquitinationKARGGLSGPQGGRAR
HHCCCCCCCCCCCHH
14.2329967540
188UbiquitinationARGAMAHVGSRKRSR
HHHHHCCCCCCCHHH
63.14-
188UbiquitinationARGAMAHVGSRKRSR
HHHHHCCCCCCCHHH
63.1422505724
190O-linked_GlycosylationGAMAHVGSRKRSRSR
HHHCCCCCCCHHHHH
47.8230379171
190PhosphorylationGAMAHVGSRKRSRSR
HHHCCCCCCCHHHHH
47.8229396449
192UbiquitinationMAHVGSRKRSRSRSR
HCCCCCCCHHHHHHH
35.3332015554
198PhosphorylationRKRSRSRSRSRGRGS
CCHHHHHHHHCCCCH
30.83-
200UbiquitinationRSRSRSRSRGRGSEK
HHHHHHHHCCCCHHH
35.87-
200PhosphorylationRSRSRSRSRGRGSEK
HHHHHHHHCCCCHHH
35.87-
200UbiquitinationRSRSRSRSRGRGSEK
HHHHHHHHCCCCHHH
35.8721963094
205PhosphorylationSRSRGRGSEKRKKKS
HHHCCCCHHHHHHHC
35.87-
208UbiquitinationRGRGSEKRKKKSRKD
CCCCHHHHHHHCCCC
35.8724816145
211UbiquitinationGSEKRKKKSRKDTSR
CHHHHHHHCCCCCCC
35.8732015554
212PhosphorylationSEKRKKKSRKDTSRN
HHHHHHHCCCCCCCC
35.87-
216PhosphorylationKKKSRKDTSRNCSAS
HHHCCCCCCCCCCCC
35.8720068231
217PhosphorylationKKSRKDTSRNCSAST
HHCCCCCCCCCCCCH
35.8720068231
217 (in isoform 3)Phosphorylation-35.8728102081
217 (in isoform 4)Phosphorylation-35.8728102081
219UbiquitinationSRKDTSRNCSASTSQ
CCCCCCCCCCCCHHH
35.4929967540
221PhosphorylationKDTSRNCSASTSQGR
CCCCCCCCCCHHHCC
46.1325849741
221 (in isoform 2)Phosphorylation-46.13-
221 (in isoform 3)Phosphorylation-46.1329743597
221 (in isoform 4)Phosphorylation-46.1329743597
223PhosphorylationTSRNCSASTSQGRKA
CCCCCCCCHHHCCCC
45.3020068231
223 (in isoform 3)Phosphorylation-45.3023663014
223 (in isoform 4)Phosphorylation-45.3023663014
224PhosphorylationSRNCSASTSQGRKAS
CCCCCCCHHHCCCCC
46.4420068231
224 (in isoform 3)Phosphorylation-46.4425159151
224 (in isoform 4)Phosphorylation-46.4425159151
225PhosphorylationRNCSASTSQGRKAST
CCCCCCHHHCCCCCC
52.9630576142
225 (in isoform 3)Phosphorylation-52.9625159151
225 (in isoform 4)Phosphorylation-52.9625159151
229 (in isoform 3)Phosphorylation-53.8329514088
229 (in isoform 4)Phosphorylation-53.8329514088
231PhosphorylationTSQGRKASTAPGAEA
HHHCCCCCCCCCCCC
61.3323927012
231UbiquitinationTSQGRKASTAPGAEA
HHHCCCCCCCCCCCC
61.3329967540
231 (in isoform 2)Phosphorylation-61.3325849741
231 (in isoform 5)Phosphorylation-61.3325849741
232PhosphorylationSQGRKASTAPGAEAS
HHCCCCCCCCCCCCC
46.7527273156
232 (in isoform 2)Phosphorylation-46.7522985185
232 (in isoform 5)Phosphorylation-46.7522985185
239PhosphorylationTAPGAEASPSPCITE
CCCCCCCCCCCCCCH
67.6929255136
241PhosphorylationPGAEASPSPCITERS
CCCCCCCCCCCCHHH
50.6630266825
244UbiquitinationEASPSPCITERSKQK
CCCCCCCCCHHHHHH
12.6322505724
245PhosphorylationASPSPCITERSKQKA
CCCCCCCCHHHHHHH
62.4130266825
248PhosphorylationSPCITERSKQKARRR
CCCCCHHHHHHHHHH
52.84-
256PhosphorylationKQKARRRTRSSSSSS
HHHHHHHHHCCCCCC
41.91-
256UbiquitinationKQKARRRTRSSSSSS
HHHHHHHHHCCCCCC
41.9121963094
258PhosphorylationKARRRTRSSSSSSSS
HHHHHHHCCCCCCCC
39.90-
259PhosphorylationARRRTRSSSSSSSSS
HHHHHHCCCCCCCCC
21.8730576142
260PhosphorylationRRRTRSSSSSSSSSS
HHHHHCCCCCCCCCC
2.9725884760
261PhosphorylationRRTRSSSSSSSSSSS
HHHHCCCCCCCCCCC
60.75-
262PhosphorylationRTRSSSSSSSSSSSS
HHHCCCCCCCCCCCC
25.86-
263PhosphorylationTRSSSSSSSSSSSSS
HHCCCCCCCCCCCCC
29.7617081983
264PhosphorylationRSSSSSSSSSSSSSS
HCCCCCCCCCCCCCC
50.96-
264UbiquitinationRSSSSSSSSSSSSSS
HCCCCCCCCCCCCCC
50.9629967540
265PhosphorylationSSSSSSSSSSSSSSS
CCCCCCCCCCCCCCC
6.80-
266PhosphorylationSSSSSSSSSSSSSSS
CCCCCCCCCCCCCCC
54.59-
267PhosphorylationSSSSSSSSSSSSSSS
CCCCCCCCCCCCCCC
43.0730576142
268PhosphorylationSSSSSSSSSSSSSSS
CCCCCCCCCCCCCCC
6.6319664994
269PhosphorylationSSSSSSSSSSSSSSS
CCCCCCCCCCCCCCC
14.2619664994
270PhosphorylationSSSSSSSSSSSSSSS
CCCCCCCCCCCCCCC
25.8319664994
271PhosphorylationSSSSSSSSSSSSSSS
CCCCCCCCCCCCCCC
27.9519664994
272PhosphorylationSSSSSSSSSSSSSSS
CCCCCCCCCCCCCCC
29.4019664994
273PhosphorylationSSSSSSSSSSSSSSS
CCCCCCCCCCCCCCC
44.06-
274PhosphorylationSSSSSSSSSSSSSSS
CCCCCCCCCCCCCCC
58.91-
275PhosphorylationSSSSSSSSSSSSSSS
CCCCCCCCCCCCCCC
61.54-
276PhosphorylationSSSSSSSSSSSSSSD
CCCCCCCCCCCCCCC
65.06-
277PhosphorylationSSSSSSSSSSSSSDG
CCCCCCCCCCCCCCC
70.72-
278PhosphorylationSSSSSSSSSSSSDGR
CCCCCCCCCCCCCCC
19.93-
279PhosphorylationSSSSSSSSSSSDGRK
CCCCCCCCCCCCCCH
30.21-
280PhosphorylationSSSSSSSSSSDGRKK
CCCCCCCCCCCCCHH
12.59-
282PhosphorylationSSSSSSSSDGRKKRG
CCCCCCCCCCCHHCC
37.41-
285MethylationSSSSSDGRKKRGKYK
CCCCCCCCHHCCCHH
52.41-
292MethylationRKKRGKYKDKRRKKK
CHHCCCHHHHHHHHH
2.61-
293UbiquitinationKKRGKYKDKRRKKKK
HHCCCHHHHHHHHHH
34.3529967540
297UbiquitinationKYKDKRRKKKKKRKK
CHHHHHHHHHHHHHH
47.59-
304UbiquitinationKKKKKRKKLKKKGKE
HHHHHHHHHHHHHHH
40.4829967540
309UbiquitinationRKKLKKKGKEKAEAQ
HHHHHHHHHHHHHHH
35.88-
310 (in isoform 5)Phosphorylation-4.1926852163
312UbiquitinationLKKKGKEKAEAQQVE
HHHHHHHHHHHHHHH
38.0029967540
322UbiquitinationAQQVEALPGPSLDQW
HHHHHCCCCCCHHHH
56.38-
325PhosphorylationVEALPGPSLDQWHRS
HHCCCCCCHHHHHHC
35.2625159151
327UbiquitinationALPGPSLDQWHRSAG
CCCCCCHHHHHHCCC
11.3022505724
328UbiquitinationLPGPSLDQWHRSAGE
CCCCCHHHHHHCCCC
4.2024816145
331MethylationPSLDQWHRSAGEEED
CCHHHHHHCCCCCCC
3.30-
332PhosphorylationSLDQWHRSAGEEEDG
CHHHHHHCCCCCCCC
7.6619664994
334UbiquitinationDQWHRSAGEEEDGPV
HHHHHCCCCCCCCCC
41.69-
339UbiquitinationSAGEEEDGPVLTDEQ
CCCCCCCCCCCCHHH
44.8021963094
343PhosphorylationEEDGPVLTDEQKSRI
CCCCCCCCHHHHHHH
43.4025159151
347UbiquitinationPVLTDEQKSRIQAMK
CCCCHHHHHHHHHCC
26.1524816145
348PhosphorylationVLTDEQKSRIQAMKP
CCCHHHHHHHHHCCC
22.4426074081
350UbiquitinationTDEQKSRIQAMKPMT
CHHHHHHHHHCCCCC
6.7829967540
351UbiquitinationDEQKSRIQAMKPMTK
HHHHHHHHHCCCCCH
10.0429967540
354AcetylationKSRIQAMKPMTKEEW
HHHHHHCCCCCHHHH
2.2725953088
357PhosphorylationIQAMKPMTKEEWDAR
HHHCCCCCHHHHHHH
19.8526074081
358UbiquitinationQAMKPMTKEEWDARQ
HHCCCCCHHHHHHHH
6.6729967540
362UbiquitinationPMTKEEWDARQSIIR
CCCHHHHHHHHHHHH
29967540
364UbiquitinationTKEEWDARQSIIRKV
CHHHHHHHHHHHHHH
22505724
366PhosphorylationEEWDARQSIIRKVVD
HHHHHHHHHHHHHCC
23401153
370AcetylationARQSIIRKVVDPETG
HHHHHHHHHCCCCCC
26051181
370UbiquitinationARQSIIRKVVDPETG
HHHHHHHHHCCCCCC
29967540
375UbiquitinationIRKVVDPETGRTRLI
HHHHCCCCCCCEEEE
22505724
376UbiquitinationRKVVDPETGRTRLIK
HHHCCCCCCCEEEEC
21963094
383SumoylationTGRTRLIKGDGEVLE
CCCEEEECCCHHHHH
-
383SumoylationTGRTRLIKGDGEVLE
CCCEEEECCCHHHHH
28112733
383UbiquitinationTGRTRLIKGDGEVLE
CCCEEEECCCHHHHH
22505724
384UbiquitinationGRTRLIKGDGEVLEE
CCEEEECCCHHHHHH
29967540
387UbiquitinationRLIKGDGEVLEEIVT
EEECCCHHHHHHHHC
21963094
394PhosphorylationEVLEEIVTKERHREI
HHHHHHHCHHHHHHH
21406692
395UbiquitinationVLEEIVTKERHREIN
HHHHHHCHHHHHHHH
21963094
403UbiquitinationERHREINKQATRGDC
HHHHHHHHHCCHHHH
29967540
407MethylationEINKQATRGDCLAFQ
HHHHHCCHHHHHHHH
-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of AR6P4_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of AR6P4_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of AR6P4_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
AR6P4_HUMANARL6IP4physical
25416956
THAP1_HUMANTHAP1physical
25416956
JMJD6_HUMANJMJD6physical
26186194
CSK22_HUMANCSNK2A2physical
26186194
ZRAB2_HUMANZRANB2physical
26186194
EIF3J_HUMANEIF3Jphysical
26186194
SRPK1_HUMANSRPK1physical
26186194
CCDC9_HUMANCCDC9physical
26186194
NCBP3_HUMANC17orf85physical
26186194
ZC3HE_HUMANZC3H14physical
26186194
UBP7_HUMANUSP7physical
26186194
GPAM1_HUMANGPALPP1physical
26186194
PI42C_HUMANPIP4K2Cphysical
26186194
PI42B_HUMANPIP4K2Bphysical
26186194
PI42A_HUMANPIP4K2Aphysical
26186194
ACY1_HUMANACY1physical
26186194
GRB2_HUMANGRB2physical
25814554
P55G_HUMANPIK3R3physical
25814554
CCDC9_HUMANCCDC9physical
28514442
JMJD6_HUMANJMJD6physical
28514442
EIF3J_HUMANEIF3Jphysical
28514442
PI42C_HUMANPIP4K2Cphysical
28514442
PI42B_HUMANPIP4K2Bphysical
28514442
GPAM1_HUMANGPALPP1physical
28514442
PI42A_HUMANPIP4K2Aphysical
28514442
NCBP3_HUMANC17orf85physical
28514442
UBP7_HUMANUSP7physical
28514442
ZC3HE_HUMANZC3H14physical
28514442
ZRAB2_HUMANZRANB2physical
28514442
SRPK1_HUMANSRPK1physical
28514442
CSK22_HUMANCSNK2A2physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of AR6P4_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-271, AND MASSSPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-271, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-178; SER-180 ANDSER-271, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-271, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-129 AND SER-271, ANDMASS SPECTROMETRY.

TOP